Nicholas Investment Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Sell
25,356
-157,184
-86% -$19M 0.15% 154
2026
Q1
$29.8M Buy
182,540
+2,130
+1% +$327K 2.15% 2
2025
Q4
$31.4M Sell
180,410
-41
-0% -$7.48K 2.29% 2
2025
Q3
$26M Sell
180,451
-14,943
-8% -$1.83M 1.99% 4
2025
Q2
$19.7M Sell
195,394
-28,537
-13% -$2.18M 1.75% 5
2025
Q1
$17.1M Buy
223,931
+41,188
+23% +$3.15M 1.76% 5
2024
Q4
$12.6M Buy
182,743
+81,598
+81% +$5.88M 1.11% 19
2024
Q3
$7.38M Buy
101,145
+26,274
+35% +$1.94M 0.68% 43
2024
Q2
$5.02M Buy
+74,871
New +$2.9M 0.52% 66
2019
Q3
Sell
-157,016
Closed -$4.02M 209
2019
Q2
$4.02M Buy
157,016
+33,324
+27% +$928K 0.37% 98
2019
Q1
$3.6M Buy
+123,692
New +$3.21M 0.32% 106
2015
Q3
Sell
-36,737
Closed -$897K 307
2015
Q2
$897K Sell
36,737
-20,387
-36% -$463K 0.06% 293
2015
Q1
$1.19M Buy
+57,124
New +$1.01M 0.07% 286
2014
Q4
Sell
-165,473
Closed -$2.16M 310
2014
Q3
$2.16M Buy
165,473
+33,398
+25% +$504K 0.13% 229
2014
Q2
$2.64M Buy
132,075
+2,508
+2% +$37.1K 0.16% 209
2014
Q1
$2.47M Buy
+129,567
New +$2.46M 0.2% 176

Other funds holding INSM

Nicholas Investment Partners's INSM Position: Q2 2026 in Review

Nicholas Investment Partners reduced its Insmed (INSM) stake by 86% in Q2 2026, selling an estimated $19M and leaving 25,356 shares worth $2.7M. The position accounts for 0.15% of the portfolio, ranked #154.

Nicholas Investment Partners first reported a position in INSM in Q1 2014 and has held it in 16 quarters since. The position peaked at $31.4M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Nicholas Investment Partners held 25,356 shares of Insmed worth $2.7M as of Q2 2026.
  • Nicholas Investment Partners sold 157,184 Insmed shares in Q2 2026, an estimated $19M.
  • Insmed made up 0.15% of Nicholas Investment Partners's portfolio in Q2 2026, its #154 holding.
  • Nicholas Investment Partners first reported a position in Insmed in Q1 2014 and has held it in 16 quarters since.
  • Nicholas Investment Partners's Insmed position peaked at $31.4M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.